schizophrenia

News and resources

Month: March 2025

Mar 20 2025

Schizophrenia Treatments: How They Evolved Over Time – Medical News Today

by Clinical Editor

No Comments

Schizophrenia Treatments: How They Evolved Over Time Medical News Today

Mar 20 2025

Breaking new ground in schizophrenia treatment – Action News 5

by Clinical Editor

No Comments

Breaking new ground in schizophrenia treatment Action News 5

Mar 19 2025

Addressing Challenges of Nonadherence Among Adults With Schizophrenia – Psychiatric Times

by Clinical Editor

No Comments

Addressing Challenges of Nonadherence Among Adults With Schizophrenia Psychiatric Times

Mar 19 2025

Efficacy of identifying Treatment-Resistant and non-Treatment-Resistant Schizophrenia using niacin skin flushing response combined with clinical feature – Nature.com

by Clinical Editor

No Comments

Efficacy of identifying Treatment-Resistant and non-Treatment-Resistant Schizophrenia using niacin skin flushing response combined with clinical feature Nature.com

Mar 18 2025

The Challenge of Staying in Long-Term Treatment

by Clinical Editor

No Comments

The vast majority of persons with schizophrenia do not adhere to medication, which leads to medication resistance and disability.

Mar 17 2025

Adaptation of the virtual assessment of mentalizing ability and evaluation of its utility and psychometric properties in Chinese individuals on the schizophrenia spectrum – Nature.com

by Clinical Editor

No Comments

Adaptation of the virtual assessment of mentalizing ability and evaluation of its utility and psychometric properties in Chinese individuals on the schizophrenia spectrum Nature.com

Mar 17 2025

Behind the smoke: Unmasking the link between cannabis and Schizophrenia – Yale School of Medicine

by Clinical Editor

No Comments

Behind the smoke: Unmasking the link between cannabis and Schizophrenia Yale School of Medicine

Mar 15 2025

EC approves Otsuka and Lundbeck’s Rxulti for schizophrenia – Pharmaceutical Technology

by Clinical Editor

No Comments

EC approves Otsuka and Lundbeck’s Rxulti for schizophrenia Pharmaceutical Technology

Mar 15 2025

The FDA Finally Removes a Huge Barrier to an Effective Schizophrenia Medicine – Cato Institute

by Clinical Editor

No Comments

The FDA Finally Removes a Huge Barrier to an Effective Schizophrenia Medicine Cato Institute

Mar 14 2025

Predictors of relapse after discontinuing antipsychotics in patients with schizophrenia spectrum disorders – Nature.com

by Clinical Editor

No Comments

Predictors of relapse after discontinuing antipsychotics in patients with schizophrenia spectrum disorders Nature.com